A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of ONO-4641 in patients
with relapsing-remitting multiple sclerosis over a 26-week treatment period.